References
- Bandala C, Perez-Santos JL, Lara-Padilla E, et al (2013). Effect of botulinum toxin a on proliferation and apoptosis in the t47d breast cancer cell line. Asian Pac J Cancer Prev, 14, 891-4. https://doi.org/10.7314/APJCP.2013.14.2.891
- Bermudes D, Zheng LM ,King IC (2002). Live bacteria as anticancer agents and tumor-selective protein delivery vectors. Curr Opin Drug Discov Devel, 5, 194-9.
- Bezine E, Vignard J ,Mirey G (2014). The cytolethal distending toxin effects on mammalian cells: A DNA damage perspective. Cells, 3, 592-615. https://doi.org/10.3390/cells3020592
- Engedal N, Skotland T, Torgersen ML, et al (2011). Shiga toxin and its use in targeted cancer therapy and imaging. Microb Biotechnol, 4, 32-46. https://doi.org/10.1111/j.1751-7915.2010.00180.x
- Frankel AE, Rossi P, Kuzel TM, et al (2002). Diphtheria fusion protein therapy of chemoresistant malignancies. Curr Cancer Drug Targets, 2, 19-36. https://doi.org/10.2174/1568009023333944
- Govindan R, Page N, Morgensztern D, et al (2006). Changing epidemiology of small-cell lung cancer in the united states over the last 30 years: Analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol, 24, 4539-44. https://doi.org/10.1200/JCO.2005.04.4859
- Hough CD, Sherman-Baust CA, Pizer ES, et al (2000). Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer. Cancer Res, 60, 6281-7.
- Kominsky SL, Vali M, Korz D, et al (2004). Clostridium perfringens enterotoxin elicits rapid and specific cytolysis of breast carcinoma cells mediated through tight junction proteins claudin 3 and 4. Am J Pathol, 164, 1627-33. https://doi.org/10.1016/S0002-9440(10)63721-2
- Lai CK, Lu YL, Hsieh JT, et al (2014). Development of chitosan/heparin nanoparticle-encapsulated cytolethal distending toxin for gastric cancer therapy. Nanomedicine (Lond), 9, 803-17. https://doi.org/10.2217/nnm.13.54
- Liu CC, Yang H, Zhang LL, et al (2014). Biotoxins for cancer therapy. Asian Pac J Cancer Prev, 15, 4753-8. https://doi.org/10.7314/APJCP.2014.15.12.4753
- Michl P, Buchholz M, Rolke M, et al (2001). Claudin-4: A new target for pancreatic cancer treatment using clostridium perfringens enterotoxin. Gastroenterology, 121, 678-84. https://doi.org/10.1053/gast.2001.27124
- Mizrahi A, Hochberg A, Amiur S, et al (2010). Targeting diphtheria toxin and tnf alpha expression in ovarian tumors using the h19 regulatory sequences. Int J Clin Exp Med, 3, 270-82.
- Nishihara T ,Koseki T (2004). Microbial etiology of periodontitis. Periodontol 2000, 36, 14-26. https://doi.org/10.1111/j.1600-0757.2004.03671.x
- Pastan I (1997). Targeted therapy of cancer with recombinant immunotoxins. Biochim Biophys Acta, 1333, 1-6.
- Patyar S, Joshi R, Byrav DS, et al (2010). Bacteria in cancer therapy: A novel experimental strategy. J Biomed Sci, 17, 21. https://doi.org/10.1186/1423-0127-17-21
- Qiu Y, Peng GL, Liu QC, et al (2012). Selective killing of lung cancer cells using carcinoembryonic antigen promoter and double suicide genes, thymidine kinase and cytosine deaminase (pcea-tk/cd). Cancer Lett, 316, 31-8. https://doi.org/10.1016/j.canlet.2011.10.015
- Saiki K, Konishi K, Gomi T, et al (2001). Reconstitution and purification of cytolethal distending toxin of actinobacillus actinomycetemcomitans. Microbiol Immunol, 45, 497-506. https://doi.org/10.1111/j.1348-0421.2001.tb02650.x
- Sargent JM ,Taylor CG (1989). Appraisal of the mtt assay as a rapid test of chemosensitivity in acute myeloid leukaemia. Br J Cancer, 60, 206-10. https://doi.org/10.1038/bjc.1989.252
- Sun S, Schiller JH, Spinola M, et al (2007). New molecularly targeted therapies for lung cancer. J Clin Invest, 117, 2740-50. https://doi.org/10.1172/JCI31809
- Wang S, Shu JZ, Cai Y, et al (2012). Establishment and characterization of mtdh knockdown by artificial microrna interference - functions as a potential tumor suppressor in breast cancer. Asian Pac J Cancer Prev, 13, 2813-8. https://doi.org/10.7314/APJCP.2012.13.6.2813
- Wising C, Magnusson M, Ahlman K, et al (2010). Toxic activity of the cdtb component of haemophilus ducreyi cytolethal distending toxin expressed from an adenovirus 5 vector. Apmis, 118, 143-9. https://doi.org/10.1111/j.1600-0463.2009.02573.x
- Yamamoto K, Tominaga K, Sukedai M, et al (2004). Delivery of cytolethal distending toxin b induces cell cycle arrest and apoptosis in gingival squamous cell carcinoma in vitro. Eur J Oral Sci, 112, 445-51. https://doi.org/10.1111/j.1600-0722.2004.00157.x
- Yildirim F, Baha A, Yurdakul AS, et al (2015). Comparison of single agent gemcitabine and docetaxel in second-line therapy for advanced stage non-small cell lung cancer in a university hospital in turkey. Asian Pac J Cancer Prev, 16, 7859-65. https://doi.org/10.7314/APJCP.2015.16.17.7859
- Zhou W, Wang J, Man WY, et al (2015). Sirna silencing ezh2 reverses cisplatin-resistance of human non-small cell lung and gastric cancer cells. Asian Pac J Cancer Prev, 16, 2425-30. https://doi.org/10.7314/APJCP.2015.16.6.2425